Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

51
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
51
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

374
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
374
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

119
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
119
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

886
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
886

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Sclerosing Cholangitis in a Child: A Rare Case Report.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·2025
Same author

Varied Characteristics of Recovered Patients with Biliary Atresia.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·2025
Same author

Late Referral of Biliary Atresia and Poor Clinical Outcomes.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·2025
Same author

Effectiveness of oral methylprednisolone as adjuvant therapy for clinical improvement, biochemical markers, and inflammation in infants with cholestasis.

Heliyon·2024
Same author

Expression of cytokeratin-7 and cytokeratin-19 on newborn mice induced rhesus rotavirus as biliary atresia model.

The Pan African medical journal·2022
Same author

Carotid intima-media thickness, hypertension, and dyslipidemia in obese adolescents.

The Pan African medical journal·2021

Related Experiment Video

Updated: May 20, 2025

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.5K

Dramatic Extrahepatic Cholestasis Improvement after Steroid Therapy.

Bagus Setyoboedi1,2, Rendi Aji Prihaningtyas1,2, Sjamsul Arief1,2

  • 1Department of Child Health, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.

The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|April 25, 2025
PubMed
Summary

Steroid treatment shows promise in infants with extrahepatic cholestasis potentially leading to biliary atresia. This approach may reduce inflammation and prevent disease progression, offering a new therapeutic avenue.

Keywords:
Biliary atresiaCholestasisInfantJaundiceSteroid

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

51.9K
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.3K

Related Experiment Videos

Last Updated: May 20, 2025

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.5K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

51.9K
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

1.3K

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Neonatal Care

Background:

  • Biliary atresia is a significant cause of pediatric liver transplantation.
  • Current treatments like Kasai surgery have limitations.

Observation:

  • A case report details an infant presenting with jaundice, pale stools, and dark urine.
  • Laboratory tests revealed elevated liver enzymes and cholestasis.
  • Cytomegalovirus (CMV) infection was noted concurrently.

Findings:

  • Percutaneous liver biopsy confirmed extrahepatic cholestasis.
  • Treatment with steroids and ursodeoxycholic acid led to significant clinical and biochemical improvement.
  • Improvements included reduced bilirubin levels, normalized liver enzymes, and increased hemoglobin.

Implications:

  • Steroid administration may mitigate biliary system inflammation in extrahepatic cholestasis.
  • This treatment could potentially halt the progression to biliary atresia.
  • Further research into steroid therapy for biliary atresia is warranted.